Bio Protocol raises $6.9M to scale AI-native DeSci biotech platform
Longevity Technology - 19-Sep-2025First BioAgent generated 1,000+ hypotheses, raised $900K, and drove lab testing within weeks
Join the club for FREE to access the whole archive and other member benefits.
Decentralized science company
BIO (Bio Protocol) is a decentralized science platform that reimagines how biotech research is funded and developed by combining artificial intelligence, blockchain, and community governance. Instead of relying on traditional institutions, it enables scientists, patients, and supporters to collaborate through decentralized organizations, directing funding and resources to promising projects. Its native token powers curation, fundraising, and incentive systems, while features like tokenized intellectual property and milestone-based rewards aim to increase transparency and accountability. By opening access to early-stage biotech and aligning stakeholders around shared goals, BIO seeks to accelerate breakthroughs in areas such as longevity, RNA therapies, and rare disease research.
Visit website: https://www.bio.xyz/
Details last updated 28-Sep-2025
First BioAgent generated 1,000+ hypotheses, raised $900K, and drove lab testing within weeks